Genentech begins construction of North Carolina manufacturing site
This 65,000m² facility is Genentech’s first plant on the US East Coast.
Business & Regulation
Odyssey bails on public listing as US IPO landscape stutters
Pharma’s AI prospects get nudged into the future with EU’s AI act
EU Health Data Space strikes a chord in EU harmonisation plans
EU reshapes HTAs: is the industry ready for it?
Sanofi increases ownership stake partaking in pharma buyback trend
Flu vaccine strategy on the line as new US leaders anticipated to take charge
US Border Protection warns pharma of risks with incorrect biologic importation
